-
Je něco špatně v tomto záznamu ?
MXenes in photomedicine: advances and prospects
S. Iravani, RS. Varma
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
PubMed
35708319
DOI
10.1039/d2cc01694j
Knihovny.cz E-zdroje
- MeSH
- fotochemoterapie * MeSH
- fototerapie metody MeSH
- indukovaná hypertermie * metody MeSH
- lidé MeSH
- nádory * diagnostické zobrazování farmakoterapie MeSH
- nanokompozity * chemie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
MXenes and their related nanocomposites with superior physicochemical properties such as high surface area, ease of synthesis and functionalization, high drug loading capacity, collective therapy potentials, pH-triggered drug release behavior, high photothermal conversion, and excellent photodynamic efficiency have been explored as alluring materials in photomedicine; the application of photons in medicine is facilitated for imaging and various disease treatment methods such as photothermal cancer/tumor ablation. Non-invasive theranostic strategies with synergistic activities have been developed using photothermal, photodynamic, and magnetic therapies together with remotely controlled drug/gene delivery for the diagnosis and treatment of various malignant diseases. Photothermal/photodynamic therapy and photoacoustic imaging using MXene-based structures have shown great promise in cancer phototherapy. However, hybridization and surface functionalization should be further explored to obtain biocompatible MXene-based composites/platforms with unique properties, high stability, and improved functionality in photomedicine. Toxicological and long-term biosafety assessments as well as clinical translation evaluations ought to be given high priority in research. Although some limited studies have revealed the excellent potentials of MXenes and their derivatives in photomedicine, further steps should be taken towards extensive research and detailed analysis in the field of optimizing the properties and improving the performance of these materials with a clinical and industrial outlook. Optical biosensing platforms have been developed along with electrochemical sensors and wearable sensors constructed from MXenes and their derivatives; future studies warrant the comprehensive analysis of optical transduction aspects such as colorimetry, electrochemiluminescence, photoluminescence, surface-enhanced Raman scattering, and surface plasmon resonance. Herein, the potentials of MXenes in photomedicine are deliberated encompassing important challenges and future research directions.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22025377
- 003
- CZ-PrNML
- 005
- 20221031100156.0
- 007
- ta
- 008
- 221017s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1039/d2cc01694j $2 doi
- 035 __
- $a (PubMed)35708319
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Iravani, Siavash $u Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. siavashira@gmail.com $1 https://orcid.org/http://orcid.org/0000000339857928
- 245 10
- $a MXenes in photomedicine: advances and prospects / $c S. Iravani, RS. Varma
- 520 9_
- $a MXenes and their related nanocomposites with superior physicochemical properties such as high surface area, ease of synthesis and functionalization, high drug loading capacity, collective therapy potentials, pH-triggered drug release behavior, high photothermal conversion, and excellent photodynamic efficiency have been explored as alluring materials in photomedicine; the application of photons in medicine is facilitated for imaging and various disease treatment methods such as photothermal cancer/tumor ablation. Non-invasive theranostic strategies with synergistic activities have been developed using photothermal, photodynamic, and magnetic therapies together with remotely controlled drug/gene delivery for the diagnosis and treatment of various malignant diseases. Photothermal/photodynamic therapy and photoacoustic imaging using MXene-based structures have shown great promise in cancer phototherapy. However, hybridization and surface functionalization should be further explored to obtain biocompatible MXene-based composites/platforms with unique properties, high stability, and improved functionality in photomedicine. Toxicological and long-term biosafety assessments as well as clinical translation evaluations ought to be given high priority in research. Although some limited studies have revealed the excellent potentials of MXenes and their derivatives in photomedicine, further steps should be taken towards extensive research and detailed analysis in the field of optimizing the properties and improving the performance of these materials with a clinical and industrial outlook. Optical biosensing platforms have been developed along with electrochemical sensors and wearable sensors constructed from MXenes and their derivatives; future studies warrant the comprehensive analysis of optical transduction aspects such as colorimetry, electrochemiluminescence, photoluminescence, surface-enhanced Raman scattering, and surface plasmon resonance. Herein, the potentials of MXenes in photomedicine are deliberated encompassing important challenges and future research directions.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a indukovaná hypertermie $x metody $7 D006979
- 650 12
- $a nanokompozity $x chemie $7 D053761
- 650 12
- $a nádory $x diagnostické zobrazování $x farmakoterapie $7 D009369
- 650 12
- $a fotochemoterapie $7 D010778
- 650 _2
- $a fototerapie $x metody $7 D010789
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Varma, Rajender S $u Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacký University in Olomouc, Šlechtitelů 27, 783 71 Olomouc, Czech Republic. Varma.Rajender@epa.gov $1 https://orcid.org/http://orcid.org/0000000197316228
- 773 0_
- $w MED00005180 $t Chemical communications $x 1364-548X $g Roč. 58, č. 53 (2022), s. 7336-7350
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35708319 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031100154 $b ABA008
- 999 __
- $a ok $b bmc $g 1854876 $s 1176667
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 58 $c 53 $d 7336-7350 $e 20220630 $i 1364-548X $m Chemical communications $n Chem. commun. (Lond., 1996, Print) $x MED00005180
- LZP __
- $a Pubmed-20221017